Tag: drug safety monitoring

  • Home
  • drug safety monitoring
By Vigilare Biopharma January 30, 2026Pharmacovigilance

Real-World Evidence (RWE) in Pharmacovigilance MAH Compliance and EMA’s 2026 Framework

The European Medicines Agency (EMA) is re-examining its approach to drug safety. The 2026 pharmacovigilance (PV) framework marks significant progress in using real-world evidence (RWE) to monitor medicines and inform regulatory decisions in the European

Read More
By Vigilare Biopharma December 16, 2025Pharmacovigilance

FDA Pharmacovigilance: A Comprehensive Resource for Drug Safety Surveillance in 2026

FDA Pharmacovigilance Status Quo: Do you know? The Food and Drug Administration’s (FDA’s) Adverse Event Reporting System (FAERS) contains 25 million adverse event reports in its database. The Agency processes more than 2 million ADRs

Read More